|
|
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
Christophe Hézode
,
Hélène Fontaine
,
Céline Dorival
,
Fabien Zoulim
,
Dominique Larrey
et al.
Journal articles
inserm-01057763v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
EFFICACY AND SAFETY OF TREATMENT WITH BULEVIRTIDE IN CHRONIC HEPATITIS DELTA: PRELIMINARY RESULTS OF THE REAL LIFE ANRS HD EP01 BULEDELTA COHORT
Fabien Zoulim
,
Claire Fougerou
,
Roulot Marullo Dominique
,
Sophie Metivier
,
Victor de Ledinghen
et al.
Hepatology, 2022, 76 (Supp 1), pp.S221-S223
Journal articles
hal-03922586v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
Stanislas Pol
,
Marc Bourlière
,
Sandy Lucier
,
Christophe Hézode
,
Céline Dorival
et al.
Journal articles
hal-01435007v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment a prospective cohort study
Fabrice Carrat
,
Hélène Fontaine
,
Céline Dorival
,
Mélanie Simony
,
Alpha Diallo
et al.
Journal articles
hal-02050395v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
Loriane Lair-Mehiri
,
Carmen Stefanescu
,
Thibaut Vaysse
,
David Laharie
,
Xavier Roblin
et al.
Journal articles
hal-03287300v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.
Laurent Cotte
,
Joséphine Braun
,
Caroline Lascoux-Combe
,
Corine Vincent
,
Marc-Antoine Valantin
et al.
Journal articles
hal-01118447v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Daclatasvir plus sofosbuvir with or without ribavirin in genotype 3 patients from a large French multicenter compassionate use program
Christophe Hézode
,
Victor De Ledinghen
,
Hélène Fontaine
,
Fabien Zoulim
,
Pascal Lebray
et al.
Journal articles
hal-01380169v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Predictive Factors for Hepatocellular Carcinoma in Chronic Hepatitis B Using Structural Equation Modeling: A Prospective Cohort Study
Laurent Lam
,
Hélène Fontaine
,
Marc Bourliere
,
Clovis Lusivika-Nzinga
,
Céline Dorival
et al.
Journal articles
hal-03224103v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
Christophe Hézode
,
Hélène Fontaine
,
Céline Dorival
,
Dominique Larrey
,
Fabien Zoulim
et al.
Journal articles
hal-01708037v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis
Georges‐philippe Pageaux
,
Clovis Lusivika Nzinga
,
Nathalie Ganne
,
Didier Samuel
,
Céline Dorival
et al.
Journal articles
hal-03555553v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|